Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 3, 2010, Pages 469-481

  Shimada, Kana ^a   Okabe, Taka aki ^a   Mikami, Yu ^a   Hattori, Miki ^a   Fujita, Masatoshi ^a   Kishimoto, Chiharu ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoimmune myocarditis; Cardiac function; Cytokines; Granulocyte colony stimulating factor (G CSF); Nitric oxide (NO); Tissue regeneration

Indexed keywords

INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; NITRIC OXIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SODIUM CHLORIDE; STEM CELL FACTOR RECEPTOR; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CAPILLARY DENSITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MECHANISM; HEART LEFT VENTRICLE EJECTION FRACTION; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE REGENERATION;

RATTUS; SUS;

EID: 77955277218     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.02.003     Document Type: Article

References (49)

1. Feldman A.M., McNamara D. Myocarditis. N Engl J Med 2000, 343:1388-1398.
2. Levi D., Alejos J. Diagnosis and treatment of pediatric viral myocarditis. Curr Opin Cardiol 2001, 16:77-83.
3. Cohn J.N. The management of chronic heart failure. N Engl J Med 1996, 335:490-498.
4. Dec G.W., Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994, 331:1564-1575.
5. Kodama M., Matsumoto Y., Fujiwara M., Masani F., Izumi T., Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 1990, 57:250-262.
6. Shioji K., Kishimoto C., Nakamura H., Toyokuni S., Nakayama Y., Yodoi J., et al. Upregulation of thioredoxin (TRX) expression in giant cell myocarditis in rats. FEBS Lett 2000, 472:109-113.
7. Shioji K., Kishimoto C., Sasayama S. Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis: concomitant suppression of the expression of dendritic cells. Circ Res 2001, 89:540-546.
8. + (immature T) subsets in the development of myocarditis. Circ Res 1987, 61:715-725.
9. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
10. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
11. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142.
12. Moncada S. The l-arginine: nitric oxide pathway. Acad Physiol Scand 1992, 145:201-227.
13. Moncada S., Higgs A. The l-arginine-nitric oxide pathway. N Engl J Med 1993, 329:2002-2012.
14. Hiraoka Y., Kishimoto C., Takada H., Nakamura M., Kurokawa M., Ochiai H., et al. Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase. J Am Coll Cardiol 1996, 28:1610-1615.
15. Diet A., Abbas K., Bouton C., Guillon B., Tomasello F., Fourquet S., et al. Regulation of peroxiredoxins by nitric oxide in immunostimulated macrophages. J Biol Chem 2007, 282:36199-36205.
16. Ronco M.T., Francés D., deLuján Alvarez M., Quiroga A., Monti J., Parody J.P., et al. Vascular endothelial growth factor and nitric oxide in rat liver regeneration. Life Sci 2007, 81:750-755.
17. Betters J.L., Long J.H., Howe K.S., Braith R.W., Soltow Q.A., Lira V.A., et al. Nitric oxide reverses prednisolone-induced inactivation of muscle satellite cells. Muscle Nerve 2008, 37:203-209.
18. Yuan Z., Kishimoto C., Shioji K., Nakamura H., Yodoi J., Sasayama S. Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expression. Cardiovasc Res 2002, 55:320-328.
19. Shioji K., Kishimoto C., Nakamura H., Masutani H., Yuan Z., Oka S., et al. Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation 2002, 106:1403-1409.
20. Miller F.J., Gutterman D.D., Rios C.D., Heistad D.D., Davidson B.L. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998, 82:1298-1305.
21. Takaya T., Kawashima S., Shinohara M., Yamashita T., Toh R., Sasaki N., et al. Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice. Atherosclerosis 2006, 186:402-410.
22. Neilan T., Blake S.L., Ichinose F., Raher M.J., Buys E.S., Jassal D.S., et al. Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin. Circulation 2007, 116:506-514.
23. Werner N., Nickenig G. Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med 2006, 10:318-332.
24. Sata M. Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models. Arterioscler Thromb Vasc Biol 2006, 26:1008-1014.
25. Roberts N., Jahangiri M., Xu Q. Progenitor cells in vascular disease. J Cell Mol Med 2005, 9:583-591.
26. Dzau V.J., Gnecchi M., Pachori A.S., Morello F., Melo L.G. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 2005, 46:7-18.
27. Khakoo A.Y., Finkel T. Endothelial progenitor cells. Annu Rev Med 2005, 56:79-101.
28. Rabelink T.J., de Boer H.C., de Koning E.J., van Zonneveld A.J. Endothelial progenitor cells: more than an inflammatory response?. Arterioscler Thromb Vasc Biol 2004, 24:834-838.
29. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438.
30. Orlic D., Kajstura J., Chimenti S., Bodine D.M., Leri A., Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 2001, 938:221-229.
31. Hill J.M., Syed M.A., Arai A.E., Powell T.M., Paul J.D., Zalos G., et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol 2005, 46:1643-1648.
32. Ohnishi S., Yanagawa B., Tanaka K., Miyahara Y., Obata H., Kataoka M., et al. Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J Moll Cell Cardiol 2007, 42:88-97.
33. Nagaya N., Kangawa K., Itoh T., Iwase T., Murakami S., Miyahara Y., et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005, 112:1128-1135.
34. Eriksson U., Kurrer M.O., Bingisser R., Eugster H.P., Saremaslani P., Follath F., et al. Lethal autoimmune myocarditis in interferon-γ receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction. Circulation 2001, 103:18-21.
35. + T cell-mediated experimental autoimmune myocarditis. J Immunol 2008, 180:2686-2695.
36. Sonderegger I., Iezzi G., Maier R., Schmitz N., Kurrer M., Kopf M. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J Exp Med 2008, 205:2281-2294.
37. Kodama M., Hanawa H., Saeki M., Hosono H., Inomata T., Suzuki K., et al. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 1994, 75:278-284.
38. Mathur A.N., Chang H.C., Zisoulis D.G., Stritesky G.L., Yu Q., O'Malley J.T., et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 2007, 178:4901-4907.
39. Fairweather D., Kaya Z., Shellam G.R., Lawson C.M., Rose N.R. From infection to autoimmunity. J Autoimmun 2001, 16:175-186.
40. Cunningham M.W. T cell mimicry in inflammatory heart disease. Mol Immunol 2004, 40:1121-1127.
41. Hiraoka Y., Kishimoto C., Takada H., Suzaki N., Shiraki K. Colony-stimulating factors and coxsackievirus B3 myocarditis in mice. Macrophage colony-stimulating factor suppresses acute myocarditis with increasing interferon α. Am Heart J 1995, 130:1259-1264.
42. Kishimoto C., Kuroki Y., Hiraoka Y., Ochiai H., Kurokawa M., Sasayama S. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage. Circulation 1994, 89:2836-2842.
43. Haghighat A., Weiss D., Whalin M.K., Cowan D.P., Taylor W.R. Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice. Circulation 2007, 115:2049-2054.
44. Park K.W., Kwon Y.W., Cho H.J., Shin J.I., Kim Y.J., Lee S.E., et al. G-CSF exerts dual effects on endothelial cells. Opposing actions of direct eNOS induction versus indirect CRP elevation. J Moll Cell Cardiol 2008, 45:670-678.
45. Minatoguchi S., Takemura G., Chen X.H., Wang N., Uno Y., Koda M., et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 2004, 109:2572-2580.
46. Dawn B., Guo Y., Rezazadeh A., Huang Y., Stein A.B., Hunt G., et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res 2006, 98:1098-1105.
47. Gulick T., Chung M.K., Pieper S.J., Lange L.G., Schreiner G.F. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci USA 1989, 86:6753-6757.
48. Harada M., Qin Y., Takano H., Minamino T., Zou Y., Toko H., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005, 11:305-311.
49. Hamamoto M., Tomita S., Nakatani T., Yutani C., Yamashiro S., Sueda T., et al. Granulocyte-colony stimulating factor directly enhances proliferation of human troponin I-positive cells derived from idiopathic dilated cardiomyopathy through specific receptors. J Heart Lung Transplant 2004, 23:1430-1437.